Share

    


Home / Search Results

Search Results

You searched for:

With the rise of immunotherapies, it is critical to ensure patient safety, as the toxicity profiles of immunotherapy agents are vastly different from traditional cytotoxic chemotherapies.
In the current transition to value-based care, avoidable ER utilization represents an opportunity for cost savings, but difficulties remain in determining what visits are and are not avoidable based on coding and billing data alone.
Our team of young adult administrators quietly agreed that we were not doing all that we could for our young adult cancer patients. This session was our call to action. When we returned to our program, our team pledged do more for this often forgotten about patient population—the In-Betweeners.